Home > Boards > US Listed > Biotechs > Agios Pharmaceuticals, Inc. (AGIO)

$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 458
Posts 9,982
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones GlobeNewswire Inc. - 1/12/2020 4:00:10 PM
Agios to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 GlobeNewswire Inc. - 12/23/2019 7:00:10 AM
Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relap... GlobeNewswire Inc. - 12/16/2019 4:00:10 PM
Agios Presents Updated Data for Mitapivat from Extension Phase of the DRIVE PK Study in Patients with Pyruvate Kinase Deficie... GlobeNewswire Inc. - 12/9/2019 10:00:10 AM
Agios Presents Translational Data to Further Characterize the Role of TIBSOVO® (ivosidenib) Treatment in IDH1 Mutant Acute M... GlobeNewswire Inc. - 12/9/2019 8:00:10 AM
Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Result... GlobeNewswire Inc. - 12/8/2019 9:00:10 AM
Agios Appoints Bruce Car, Ph.D., as Chief Scientific Officer GlobeNewswire Inc. - 12/2/2019 7:00:10 AM
Agios Appoints Jonathan Biller as Chief Legal Officer GlobeNewswire Inc. - 11/25/2019 7:00:10 AM
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire Inc. - 11/13/2019 10:21:25 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/8/2019 5:04:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:57:57 PM
Agios Announces Pricing of $256 Million Public Offering of Common Stock GlobeNewswire Inc. - 11/7/2019 9:17:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/6/2019 4:09:20 PM
Agios Announces Proposed Offering of Common Stock GlobeNewswire Inc. - 11/6/2019 4:01:00 PM
Agios to Present Broad Set of Clinical and Translational Data for Oncology and Rare Genetic Disease Programs at the 2019 ASH ... GlobeNewswire Inc. - 11/6/2019 9:28:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 5:10:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/31/2019 9:16:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 7:39:46 AM
Agios Reports Business Highlights and Third Quarter 2019 Financial Results GlobeNewswire Inc. - 10/31/2019 7:00:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2019 7:20:50 AM
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTA... GlobeNewswire Inc. - 10/27/2019 11:50:05 AM
Agios to Webcast Conference Call of Third Quarter 2019 Financial Results on October 31, 2019 GlobeNewswire Inc. - 10/17/2019 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/9/2019 4:20:59 PM
Agios to Present Data from AG-270 Phase 1 Dose-Escalation Study in Patients with MTAP-Deleted Tumors in a Proffered Papers Or... GlobeNewswire Inc. - 10/9/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2019 11:14:11 AM
stocktrademan   Thursday, 10/30/14 12:44:21 PM
Re: stocktrademan post# 4
Post # of 49 
$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO

Topdown market analysis:
Market is _BULLISH_
Today is _UP_
Bullish Sector _BIOTECHNOLOGY_

bullish stock in this sector

$AGIO recent news/filings

## source: finance.yahoo.com

Wed, 29 Oct 2014 17:41:34 GMT ~ Nasdaq stocks posting largest percentage increases


read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************

Wed, 29 Oct 2014 10:00:00 GMT ~ 'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals


read full: http://www.thestreet.com/story/12861472/1/mad-money-lightning-round-im-sticking-with-isis-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Tue, 28 Oct 2014 23:24:10 GMT ~ Lightning Round: GNC, Goldman and more


read full: http://www.cnbc.com/id/102128707?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102128707
*********************************************************

Tue, 28 Oct 2014 18:12:59 GMT ~ Two biotech leaders to watch


read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=D7CCEB70-396E-49E4-BD03-2CB82C69AFAC&siteid=yhoof2
*********************************************************

Mon, 27 Oct 2014 13:11:41 GMT ~ Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014

[at noodls] - CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that ...

read full: http://www.noodls.com/view/A2EF8BBB5ACD70924BD84BBCAE0F2381B1BCF76C
*********************************************************


$AGIO charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$AGIO company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AGIO/company-info
Ticker: $AGIO
OTC Market Place: Not Available
CIK code: not found
Company name: Agios Pharmaceuticals, Inc.
Incorporated In:

Business Description:

http://www.agios.com/

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its product candidates include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; and AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations. The company is also developing AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation to discover, develop, and commercialize disease-altering therapies in oncology. Agios Pharmaceuticals, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

$AGIO share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGIO extra dd links

Company name: Agios Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGIO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/news - http://finance.yahoo.com/q/h?s=AGIO+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agios+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agios+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agios+Pharmaceuticals%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGIO+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGIO



$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist